DS-1501 is a human monoclonal antibody (mAb) that targets Siglec-15/CD33L3. It inhibits the formation of osteoclasts and prevents the decline of lumbar vertebrae bone mineral density (BMD) in ovariectomized (OVX) rats. DS-1501 is applicable in osteoporosis research. Recommended isotype control: HumanIgG1kappa [Isotype Control].
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted